Idiopathic Pulmonary Fibrosis Treatment Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Idiopathic Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Treatment Market is estimated to be valued at US$ 3,853.6 million in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period of 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease … Read more